Lilly(Eli) & Company
NYSE: LLY
$747.36
Real Time Data Delayed 15 Min.
LLY Articles
ETFs are a great way for investors to get instant diversification at a low cost. But with so many ETFs available, choosing the right one for your investment goals can be daunting. In this article,...
Published:
Imagine buying a stock for 24 cents, and one day opening your brokerage account to see eye-popping returns of 55,919%. Your stock is now worth $133. Sound like a fairy tale? It isn’t. Today I’ll...
Published:
The pharmaceutical sector is one that has gone from decades of heavy investment, high growth, and consolidation to a maturing space with a few key players that have more recently provided much more...
Published:
24/7 Wall Street Insights Unlike the declining stocks of some of its pharmaceutical rivals, Eli Lilly has continually beat analysts’ forecasts and prospered accordingly. In 5 Years, Eli Lilly has...
Published:
In the movie The Social Network, there’s a scene where the investor Sean Parker is trying to sweet talk Mark Zuckerberg and says “A million dollars isn’t cool… You know what’s cool?”...
Published:
Here is an assessment of how safe the dividend at AbbVie appears to be based on a variety of metrics, including its status as a Dividend Aristocrat.
Published:
The exclusive trillion-dollar club currently has five American members — Apple (NASDAQ: AAPL) at around $3 trillion market capitalization, Microsoft at about $2.8 trillion, Google parent Alphabet...
Published:
Here are some of the top upgrades, downgrades and other analyst calls for Thursday, December 21, along with other investing news.
Published:
Thursday's top analyst upgrades and downgrades included Bumble, Coupang, Datadog, Dish Network, DraftKings, Eli Lilly, International Flavors & Fragrances, LivePerson, Novavax, Nvidia, Qualcomm and...
Published:
Thursday's top analyst upgrades and downgrades included Alphabet, Eli Lilly, Etsy, Microsoft, Mosaic, NetApp, Omega Healthcare Investors, RTX, Sherwin-Williams, Spotify Technology, Walt Disney and WW...
Published:
Monday's top analyst upgrades and downgrades included Amazon.com, AT&T, Broadcom, Corning, DraftKings, Eli Lilly, Fortinet, General Mills, Leslie’s, Microsoft, Nvidia, Plug Power, Progressive,...
Published:
Thursday's top analyst upgrades and downgrades included Antero Resources, AutoZone, Coterra Energy, Dollar General, Eli Lilly, First Horizon, Infosys, Owens Corning, Palo Alto Networks, Range...
Published:
Tuesday's top analyst upgrades and downgrades included Ally Financial, Amgen, Baidu, Bilibili, Bill.com, Coinbase Global, Eli Lilly, GE Healthcare Technologies, JPMorgan Chase, Merck, Moderna,...
Published:
Tuesday's top analyst upgrades and downgrades included Campbell Soup, DoorDash, Eli Lilly, Enterprise Products Partners, Mastercard, Oracle, Silvergate Capital, Uber Technologies, VICI Properties,...
Published:
Wednesday's top analyst upgrades and downgrades included Amgen, Archer Daniels Midland, Eli Lilly, Home Depot, Medtronic, Palantir Technologies, Snowflake, Take-Two Interactive Software, Viatris and...
Published: